Hospital
Granville Health System
Granville Health System was paid $13.31M by Medicaid between Jan 2018 and Dec 2024, across 105 billing codes. Its largest line is 99283, emergency room visit (moderate) — 33% of everything it billed.
33Billing provider infoGRANVILLE HEALTH SYSTEM
OXFORD, NC 27565
OXFORD, NC 27565
33aNPI1326061730assigned 07/26/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$13.31M
24GClaims224,121
24DCodes billed105
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#42 of 92
Median peer was paid$11.47M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PURVIS, JAMIE controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,726 | $919K | |
| 2019 | 27,713 | $925K | |
| 2020 | 24,939 | $1.08M | |
| 2021 | 32,563 | $1.83M | |
| 2022 | 33,013 | $2.80M | |
| 2023 | 35,911 | $2.64M | |
| 2024incomplete | 41,256 | $3.12M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 23,938 | 22,194 | $4.34M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 26% | 13,438 | 12,223 | $3.42M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 9,169 | 8,579 | $1.76M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.4% | 2,799 | 2,607 | $458K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 7,400 | 6,687 | $204K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 4,685 | 4,019 | $202K |
| 87428 | 1.5% | 2,991 | 2,695 | $200K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 7,857 | 7,084 | $195K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 2,214 | 1,993 | $177K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 2,023 | 1,679 | $173K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 22,320 | 19,927 | $162K |
| 80053 | Comprehensive metabolic panel | 1.2% | 19,619 | 17,468 | $159K |
93 more codes
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 1,756 | $145K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.0% | 323 | $136K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 970 | $124K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,359 | $123K |
| 0240U | <1% | 739 | $106K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,692 | $96K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,893 | $84K |
| 90836 | <1% | 2,091 | $74K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 30,603 | $66K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 292 | $61K |
| 71045 | Radiologic examination, chest; single view | <1% | 962 | $59K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 55 | $55K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 138 | $55K |
| 90837 | Psychotherapy session, about an hour | <1% | 969 | $50K |
| 83690 | <1% | 6,020 | $42K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,590 | $41K |
| 81005 | <1% | 18,544 | $41K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 305 | $39K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 472 | $33K |
| 81025 | <1% | 4,144 | $31K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 398 | $30K |
| 84484 | <1% | 3,144 | $30K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 887 | $27K |
| J3490 | Unclassified drugs | <1% | 2,510 | $25K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 635 | $21K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 621 | $20K |
| 83735 | <1% | 3,357 | $19K | |
| 87800 | <1% | 279 | $17K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 378 | $17K |
| 87503 | <1% | 1,680 | $17K | |
| 90838 | <1% | 527 | $15K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 388 | $14K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 27 | $13K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,324 | $12K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 310 | $10K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 32 | $8K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,352 | $8K |
| G0378 | Hospital observation service, per hour | <1% | 62 | $8K |
| 87390 | <1% | 291 | $7K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 12 | $7K |
| 86703 | <1% | 414 | $6K | |
| 83880 | <1% | 241 | $6K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 336 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,448 | $5K |
| 86780 | <1% | 279 | $5K | |
| 85610 | <1% | 1,657 | $5K | |
| 87088 | <1% | 517 | $5K | |
| 94761 | <1% | 174 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 262 | $4K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 30 | $4K |
| 80061 | Lipid panel | <1% | 223 | $3K |
| 59025 | Fetal non-stress test | <1% | 85 | $3K |
| 93017 | <1% | 24 | $3K | |
| 85027 | <1% | 280 | $2K | |
| A9270 | Non-covered item or service | <1% | 1,611 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 40 | $2K |
| 76770 | <1% | 13 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 289 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 32 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 149 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 633 | $1K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 616 | $1K |
| V2632 | Posterior chamber intraocular lens | <1% | 18 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 190 | $809.41 |
| 86941 | <1% | 44 | $712.33 | |
| 86850 | <1% | 44 | $684.93 | |
| 86762 | <1% | 27 | $442.30 | |
| 84702 | <1% | 40 | $352.02 | |
| 87040 | <1% | 15 | $335.49 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 43 | $333.50 |
| 85730 | <1% | 87 | $326.95 | |
| 84153 | <1% | 12 | $278.54 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 40 | $276.26 |
| 87340 | <1% | 27 | $274.84 | |
| 82951 | <1% | 14 | $208.52 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 110 | $204.51 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 55 | $204.02 |
| 82550 | <1% | 54 | $199.03 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 48 | $193.41 |
| 83721 | <1% | 24 | $193.14 | |
| 86900 | <1% | 45 | $178.82 | |
| 86901 | <1% | 45 | $171.40 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $171.36 |
| 87071 | <1% | 14 | $152.75 | |
| 83540 | <1% | 13 | $80.80 | |
| J2002 | Injection, lidocaine hcl in 5% dextrose, 1 mg | <1% | 14 | $73.91 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 47 | $54.06 |
| 86592 | <1% | 14 | $53.10 | |
| 81000 | <1% | 14 | $39.50 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 12 | $32.85 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 14 | $29.25 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 32 | $14.94 |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | <1% | 14 | $7.74 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPURVIS, JAMIE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Granville Health System | Oxford, NC | $2.94M |
| Granville Health System | Creedmoor, NC | $2.34M |
| Granville Health System | Oxford, NC | $731K |
| Granville Health System | Oxford, NC | $569K |
| Granville Health INC. | Oxford, NC | $268K |
| Granville Health INC. | Oxford, NC | $259K |
| Granville Health INC | Oxford, NC | $158K |
| Granville Health INC | Oxford, NC | $150K |
| Granville Health System | Oxford, NC | $119K |
| Granville Health System | Oxford, NC | $87K |
| Granville Health System | Oxford, NC | $37K |
| Granville Health INC. | Oxford, NC | $22K |
| Granville Health INC | Oxford, NC | $11K |
| Granville Health System | Oxford, NC | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.